Expression of SOX-2 has been investigated by immunohistochemistry analysis of normal ovarian epithelial, serous and mucinous cystadenoma and cystadenomacarcinoma specimens [28] and LIN-28 was overexpressed in different epithelial tumors including breast, lung, colon and ovarian cancer [29]. This evidence concerns the gene SOX2 and mucinous cystadenoma.